Skip to main content

Table 1 Participant characteristics across age groups, by state

From: Injecting drug use in Manipur and Nagaland, Northeast India: injecting and sexual risk behaviours across age groups

 

Manipur (n=1,657)

Nagaland (n=1,705)

 
 

18–24 years % (n)

25–34 years % (n)

35 + years % (n)

Total % (n)

p valuea

18–24 years % (n)

25–34 years % (n)

35 + years % (n)

Total % (n)

p valuea

Literacy

    

0.017

    

0.013

  Illiterate

9.4 (37)

7.5 (67)

12.5 (46)

9.1 (150)

 

18.3 (136)

23.8 (186)

25.7 (46)

21.6 (368)

 

  Literate

90.6 (355)

92.5 (830)

87.5 (322)

90.9 (1,507)

 

81.7 (607)

76.2 (597)

74.3 (133)

78.4 (1,337)

 

Marital status

    

<0.001

    

<0.001

  Never married

89.5 (351)

53.6 (481)

18.8 (69)

54.4 (901)

 

91.9 (683)

52.9 (413)

17.4 (31)

66.2 (1,127)

 

  Currently married

8.2 (32)

36.6 (328)

66.6 (245)

36.5 (605)

 

6.9 (51)

42.6 (333)

73.0 (130)

30.2 (514)

 

  Widowed/divorced/separated

2.3 (9)

9.8 (88)

14.7 (54)

9.1 (151)

 

1.2 (9)

4.5 (35)

9.6 (17)

3.6 (61)

 

Length of injecting career

    

<0.001

    

<0.001

  < 3 years

64.4 (251)

20.8 (186)

13.7 (50)

29.5 (487)

 

71.6 (530)

33.6 (262)

21.7 (38)

49.0 (830)

 

  ≥ 3 years

35.6 (139)

79.2 (708)

86.3 (316)

70.5 (1,163)

 

28.4 (210)

66.4 (517)

78.3 (137)

51.0 (864)

 

Most commonly injected drug

    

<0.001

    

0.004

  Heroin

87.8 (344)

96.8 (868)

99.5 (366)

95.2 (1,578)

 

14.9 (111)

18.8 (147)

8.4 (15)

16.0 (273)

 

  SPb

6.9 (27)

2.2 (20)

0.3 (1)

2.9 (48)

 

82.1 (610)

77.7 (608)

86.0 (154)

80.5 (1,372)

 

  Other

5.4 (21)

1.0 (9)

0.3 (1)

1.9 (31)

 

3.0 (22)

3.6 (28)

5.6 (10)

3.5 (60)

 

Frequency of injecting

    

0.140

    

0.244

  Injected less than daily

35.1 (133)

33.0 (291)

28.5 (101)

32.5 (525)

 

79.9 (504)

76.1(537)

78.2 (133)

77.9 (1,174)

 

  Injected daily

64.9 (246)

67.0 (590)

71.5 (254)

67.5 (1,090)

 

20.1 (127)

23.9 (169)

21.8 (37)

22.1 (333)

 

Place usually procure needles/syringes

    

0.391

    

<0.001

  Needle syringe programme

77.3 (303)

79.5 (713)

82.9 (305)

79.7 (1,321)

 

65.3 (483)

51.4 (402)

40.3 (71)

56.3 (956)

 

  Chemist / pharmacy

19.4 (76)

17.8 (160)

15.2 (56)

17.6 (292)

 

32.6 (241)

47.6 (372)

58.5 (103)

42.2 (716)

 

  Other

3.3 (13)

2.7 (24)

1.9 (7)

2.7 (44)

 

2.2 (16)

1.0 (8)

1.1 (2)

1.5 (26)

 

Shared needle/syringe - past month

    

0.474

    

0.918

  No

85.2 (310)

87.3 (748)

88.1 (310)

87.0 (1,368)

 

62.0 (426)

62.2 (423)

60.4 (90)

61.9 (939)

 

  Yes

14.8 (54)

12.7 (109)

11.9 (42)

13.0 (205)

 

38.0 (261)

37.8 (257)

39.6 (59)

38.1 (577)

 

Drew drugs from common container at last injection

    

0.005

    

0.786

  No

72.7 (285)

75.5 (677)

82.3 (303)

76.3 (1,265)

 

48.9 (363)

50.6 (396)

50.3 (90)

49.8 (849)

 

  Yes

27.3 (107)

24.5 (220)

17.7 (65)

23.7 (392)

 

51.0 (379)

49.4 (387)

49.7 (89)

50.1 (855)

 

Ever had sex

    

<0.001

    

<0.001

  No

25.8 (101)

9.6 (86)

4.9 (18)

12.4 (205)

 

14.8 (110)

3.3 (26)

0.0 (0)

8.0 (136)

 

  Yes

74.2 (291)

90.4 (811)

95.1 (350)

87.6 (1,452)

 

85.2 (632)

96.7 (757)

100.0 (179)

92.0 (1,568)

 

Number of female sex partners - past yearc

    

<0.001

    

<0.001

  None

17.5 (51)

22.4 (182)

19.4 (68)

20.7 (301)

 

3.4 (21)

8.3 (62)

16.7 (29)

7.3 (112)

 

  1

32.3 (94)

51.8 (420)

69.7 (244)

52.2 (758)

 

30.0 (186)

42.3 (315)

50.0 (87)

38.2 (588)

 

  ≥ 2 Partners

50.2 (146)

25.8 (209)

10.9 (38)

27.1 (393)

 

66.6 (413)

49.3 (367)

33.3 (58)

54.5 (838)

 

Female sexual partners – past yearc

          

  Regular non-paid partner(s)

44.3 (129)

56.8 (461)

72.6 (254)

58.1 (844)

<0.001

75.1 (471)

78.2 (589)

82.7 (148)

77.5 (1,208)

0.081

  Casual non-paid partner(s)

47.8 (139)

21.8 (177)

9.1 (32)

24.0 (348)

<0.001

55.1 (343)

39.1 (292)

27.5 (49)

44.2 (684)

<0.001

  Paid partner(s)

17.9 (52)

14.8 (120)

6.3 (22)

13.4 (194)

<0.001

5.6 (35)

5.2 (39)

8.9 (16)

5.8 (90)

0.149

Consistent condom use with different types of female partners – past yeard

          

  Regular non-paid partner(s)

16.7 (21)

7.0 (32)

9.9 (25)

9.4 (78)

0.004

17.7 (82)

9.1 (53)

2.7 (4)

11.7 (139)

<0.001

  Casual non-paid partner(s)

28.4 (40)

16.6 (30)

17.6 (6)

21.3(76)

0.032

38.7 (135)

27.8 (83)

16.0 (8)

32.4 (226)

<0.001

  Paid partner(s)

57.7 (30)

43.3 (52)

50.0 (11)

47.9 (93)

0.219

52.8 (19)

34.1 (14)

18.8 (3)

38.7 (36)

0.049

Ever had an HIV test

31.6 (124)

58.7 (525)

62.0 (228)

53.0 (877)

0.000

37.2 (269)

46.3 (342)

43.8 (70)

42.0 (681)

0.002

Tested positive for different types of infectionse

          

  HIV

5.9 (9)

27.3 (138)

65.0 (106)

30.8 (253)

0.000

0.0 (0)

2.3 (9)

2.7 (3)

1.4 (12)

0.021

  Hepatitis C (HCV)

53.3 (81)

74.9 (379)

90.2 (147)

73.9 (607)

0.000

8.8 (28)

16.4 (65)

21.4 (24)

14.1 (117)

0.001

  Reactive syphilis serology

2.0 (3)

4.3 (22)

4.3 (7)

3.9 (32)

0.398

7.5 (24)

16.1 (64)

20.5 (23)

13.4 (111)

<0.001

  Chlamydia

2.6 (4)

2.0 (10)

0.6 (1)

1.8 (15)

0.384

12.5 (40)

7.6 (30)

4.5 (5)

9.1 (75)

0.014

  1. ap value based on chi-square test.
  2. bSpasmoproxyvon (SP), the brand name for a synthetic opiate analgesic containing dextropropoxyphene, dicyclomine hydrochloride and paracetamol.
  3. cAmong sexually active participants.
  4. dReported that, in general, condoms are used every time with this type of partner. Analysis based on sub-sample of participants who reported having these types of partners in the preceding 12 months.
  5. eBased on IBBA data only (Manipur n =821, Nagaland n =829), as BTS did not collect biological data.